arrow
G

G. Créhange

assistance publique hopitaux paris (aphp)
H指数:34
被引数:5,185

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Randomized phase III trial with a factorial design assessing the efficacy and safety of darolutamide and stereotactic dose-escalated radiotherapy in patients with high-risk localized prostate cancer: the PEACE 7 (GETUG-AFU 45) study protocol

评估达罗他胺联合立体定向剂量递增放疗在高风险局限性前列腺癌患者中有效性和安全性的析因设计随机III期试验:PEACE 7 (GETUG-AFU 45) 研究方案

2026-09-180
OAAI
Interpretable AIto predict anal cancer local failure at 3 years with the FFCD Anabase prospective multicentric cohort

可解释AI预测FFCD Anabase前瞻性多中心队列中3年肛门癌局部复发

2026-08-010
PRE
The French Reirradiation Team for Research and Treatment (FReTREAT): A national collaborative model by Unitrad for advancing reirradiation research, education, and clinical practice in France

法国再照射研究治疗组(FReTREAT):Unitrad为推动法国再照射研究、教育和临床实践的国家协作模式

2026-02-010
PRE
Understanding management strategies for metastatic hormone-sensitive prostate cancer: A multidisciplinary survey in France

理解转移性激素敏感性前列腺癌的管理策略:一项法国多学科调查

2025-12-010
OAAI
Sparing effects of FLASH irradiation in patient-derived lung tissue

FLASH照射对病人来源肺组织的保护作用

2025-09-060
OAAI
Predicting tumor recurrence site after reirradiation in head and neck cancer: a retrospective external validation of a published [18F]-FDG PET radiomic signature

预测头颈癌再放疗后肿瘤复发部位:一项已发表[18F]-FDG PET放射组学特征的回顾性外部验证

2025-08-200
PRE
Post-operative hypofractionated stereotactic radiotherapy for brain metastases from lung and breast cancer in patients without prior WBRT: a retrospective dose escalation study

肺癌和乳腺癌脑转移患者术后未行全脑放疗的剂量递增研究:一项回顾性研究,探讨非全脑放疗后的立体定向放射治疗。

2025-04-240
PRE
Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer

PROTECT试验中的放射治疗质量保证——一项比较质子与光子疗法治疗食管癌患者的欧洲随机III期试验

2025-03-130
OA
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)
2024-05-016
OAAI
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE
2024-01-061
PRE